• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 4 of 30
A hand holding an Ivermectin tablet, with the bottle in the other hand
HealthIvermectin is being touted as a cure for COVID and cancer. Here’s what science says
By Beth GreenfieldApril 2, 2025
Photo of Mark Cuban
HealthMark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By Ani FreedmanApril 1, 2025
Medication taken by 1 in 8 Americans linked to substantial increase in the risk of sudden cardiac death
HealthMedication taken by 1 in 8 Americans linked to substantial increase in the risk of sudden cardiac death
By Ani FreedmanMarch 30, 2025
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
FinanceVietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By AFPMarch 27, 2025
China says U.S. owes ‘big thank you’ on fentanyl, urges talks
PoliticsChina says U.S. owes ‘big thank you’ on fentanyl, urges talks
By BloombergMarch 13, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
RetailRoche, Zealand Pharma in $5.3 billion pact for obesity drugs
By Paula Doenecke, Naomi Kresge and BloombergMarch 12, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Ari Raptis, CEO of Talaria Transportation.
CommentaryI’m running a multimillion-dollar business—but it’s federally illegal
By Ari RaptisFebruary 25, 2025
Robert F. Kennedy Jr.
HealthWith RFK Jr. in charge, supplement makers see chance to cash in
By KFF Health News and Arthur AllenFebruary 25, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
Donald Trump in the Oval Office
PoliticsTrump floats 25% tariffs on U.S. auto, drug, chip imports
By Hadriana Lowenkron, Josh Wingrove and BloombergFebruary 19, 2025
Here’s a look into Silicon Valley’s ‘executive psychedelic slumber parties’ that cost over $3,000
MindHere’s a look into Silicon Valley’s ‘executive psychedelic slumber parties’ that cost over $3,000
By Ani FreedmanFebruary 18, 2025
A woman holds a medicine bottle while reading instructions.
HealthGen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By Lindsey LeakeFebruary 14, 2025
Canada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
PoliticsCanada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
By The Associated PressFebruary 12, 2025
A young woman undergoes a brain scan.
HealthMeet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By Lindsey LeakeFebruary 6, 2025
1
  • 2
  • 3
  • 4
  • 5
  • 6
...30
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Fortune EditorsApril 2, 2026
Innovation
Google CEO Sundar Pichai says we’re just a decade away from a new normal of extraterrestrial data centersplaceholder alt text
By Fortune EditorsApril 3, 2026
Success
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothingplaceholder alt text
By Fortune EditorsApril 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.